Related Articles
Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non‑small cell lung cancer Retraction in /10.3892/ol.2022.13595
Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression
Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 in vitro
Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer
Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells